Established in July 2020, Westlake Omics is a micro-world data company empowered by Al. Its primary goal is to enhance precision medicine and facilitate drug research and development by leveraging technological innovations in proteomics and multimodal big data technology.

Westlake Omics has partnered with more than 100 prestigious universities, research institutes, hospitals, and pharmaceutical companies both domestically and internationally. Additionally, it holds ownership of multiple national patents and software copyrights.

China Future Healthcare Rankings 2024-Top 100 Medical Industrial Chain Services Companies
Second Prize for Innovative Technology Products of Tumor Biomarker in 2023
2023 Top 50 Life Health Honor Rolls by Venture50
China Future Healthcare Rankings 2023-Top 100 China Innovation Medical Devices Companies
Enterprise with Characteristics of "Specialization, Refinement, Uniqueness and Novelty" in Zhejiang Province
Industrialization base of research center for industries of the future Westlake University
Forbes China · 100 Young Elite Returnees
Fortune China's 2023 list of "Most Socially Influential Startups"
2022 Emerging Company of College Economy in the Xihu District
High and New Technology Enterprise Certificate
the Most Potential ScienceAI Startup Enterprises TOP 10
2022 China's TOP 100 Future Unicorns
2022 Venture Top 50 of Healthcare
2022 Venture Top 50 of New Buds Honor Rolls
Hangzhou Young Eagle Plan Enterprise
High-tech Research and Development Centers
2022 Hangzhou Quasi-unicorn Company
Technology-based Small and Medium-sized Enterprises in Zhejiang Province
2021 Venture Top 50 of New Buds Honor Rolls
West Lake Talent Program Category A Project




Join us now! Explore what it is like to work in wOmics!

Online enquiries